Occurrence of resistance mutation and clonal expansion in Helicobacter pylori multiple-strain infection: A potential risk in clarithromycin-based therapy

Clinical Infectious Diseases

Volumn 28, Issue 6, 1999, Pages 1305-1307

  Enroth, Helena ^a,b,c   Björkholm, Britta ^a,b,c   Engstrand, Lars ^a,b,c  

^a KAROLINSKA INSTITUTE   (Sweden)

^b SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CLARITHROMYCIN; ANTIINFECTIVE AGENT; RNA 23S;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL INFECTION; BACTERIUM COLONY; BACTERIUM ISOLATE; DNA FINGERPRINTING; ERADICATION THERAPY; GENE MUTATION; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; DRUG EFFECT; GENETICS; HELICOBACTER INFECTION; MUTATION; RISK;

ANTI-BACTERIAL AGENTS; CLARITHROMYCIN; DRUG RESISTANCE, MICROBIAL; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MUTATION; RISK; RNA, RIBOSOMAL, 23S;

EID: 0032587132     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/514796     Document Type: Article

References (16)

1. 1. Hultén K, Gibreel A, Sköld O, Engstrand L. Macrolide resistance in Helicobacter pylori: mechanism and stability in strains from clarithromycin-treated patients. Antimicrob Agents Chemother 1997; 41:2550-3.
2. 2. Glupczynski Y, Labbé M, Hansen W, Crokaert F, Yourassowsky E. Evaluation of the Etest for quantitative antimicrobial susceptibility testing of Helicobacter pylori. J Clin Microbiol 1991; 29:2072-5.
3. 3. Versalovic J, Shortridge D, Kibler K, et al. Mutations in 23S rRNA are associated with clarithromycin resistance in Helicobacter pylori. Antimicrob Agents Chemother 1996; 40:477-80.
4. 4. Debets-Ossenkopp YJ, Sparrius M, Kusters JG, Kolkman JJ, Vandenbroucke-Grauls CMJE. Mechanism of clarithromycin resistance in clinical isolates of Helicobacter pylori. FEMS Microbiol Lett 1996; 142: 37-42.
5. 5. Stone GG, Shortridge D, Klamm RK., et al. Identification of a 23S rRNA gene mutation in clarithromycin resistant Helicobacter pylori. Helicobacter 1996; 1:227-8.
6. 6. Stone GG, Shortridge D, Versalovic J, et al. A PCR-oligonucleotide ligation assay to determine the prevalence of 23S rRNA gene mutations in clarithromycin-resistant Helicobacter pylori. Antimicrob Agents Chemother 1997; 41:712-4.
7. 7. Jorgensen M, Daskalopoulos G, Warburton V, Mitchell HM, Hazell SL. Multiple strain colonization and metronidazole resistance in Helicobacter pylori infected patients: identification from sequential and multiple biopsy specimens. J Infect Dis 1996; 174:631-5.
8. 8. Martínez JL, Blázques J, Baquero F. Non-canonical mechanisms of antibiotic resistance. Eur J Clin Microbiol Infect Dis 1994; 13:1015-22.
9. 9. van der Hulst RWM, Rauws EAJ, Köycü B, et al. Helicobacter pylori is virtually absent after successful eradication. J Infect Dis 1997; 176: 196-200.
10. 10. Enroth H, Nyren O, Engstrand L. One stomach - one strain: does Helicobacter pylori strain variation influence disease outcome? Dig Dis Sci 1999; 44:102-7.
11. 11. Forbes KJ, Fang Z, Pennington TH. Allelic variation in the Helicobacter pylori flagellin genes flaA and flaB: its consequences for strain typing schemes and population structure. Epidemiol Infect 1995; 114:257-66.
12. 12. Huratado A, Owen RJ, Desai M, Flagellin gene profiling of Helicobacter pylori infecting symptomatic and asymptomatic individuals. Res Microbiol 1994; 145:585-94.
13. 13. Leying H, Suerbaum S, Geis G, Haas R. Cloning and characterisation of a Helicobacter pylori flagellin gene. Mol Microbiol 1992; 6:2863-74.
14. 14. Taylor DE, Eaton M, Chang N, Salama SM. Construction of a Helicobacter pylori genome map and demonstration of diversity at the genome level. J Bacteriol 1992; 174:6800-6.
15. 15. Blaser MJ. The versatility of Helicobacter pylori in the adaptation to the human stomach. J Physiol Pharmacol 1997; 48:307-14.
16. 16. Blaser MJ. Heterogeneity of Helicobacter pylori. Eur J Gastroenterol Hepatol 1997; 9(suppl 1):S3-7.